acetyl l carnitine and myasthenia gravis Cour Pharmaceuticals set to advance CNP-106 for Myasthenia gravis - The Lancet
Description
(2020) 11(November):19
05186-2/asset/5421a2f6-be45-46ba-b83d-abba09eb7c93/main.assets/gr1_lrg.jpg)
[DOI] [Google Scholar] 44.Xi J., Yuan J.E., Zhang Y., Nevorski D., Wang Z., Zhou Y
Less common side effects Temporary skin sensitivity may occur as GHK-Cu stimulates collagen remodeling
These drops usually have prostaglandin analogs
